The study has demonstrated the association of Cdc25A, a cell-cycle-activating phosphatase overexpressed in breast cancer, with poor prognosis, which enhances the stability of FOXO1, and thereby directly stimulates the transcription of MMP1 [145]. The gene discussed is FOXO1; the disease is breast carcinoma.